Fortrans (Macrogol) powder for solution 4 sachets
English product name
Fortrans®
Release form
Powder for preparation of solution for ingestion
Description Fortrans:
Powder for preparation of solution for absorption in white, easily soluble in water.
1 pack.
macrogol 4000 64g
Auxiliary substances: sodium chloride - 1.46 g, potassium chloride - 0.75 g, sodium hydrogen carbonate - 1.68 g, sodium sulphate anhydrous - 5.7 g, sodium saccharinate - 0.1 g.
73.69 g - paper laminated bags (4) - cardboard packs.
ATC codes
A06AD15 Macrogol
Clinical-pharmacological groups / Group affiliation
Osmotic laxative, used for intestinal lavage
Active substance
macrogol 4000
Pharmacotherapy group Fortrans
Laxative
Storage Conditions
The drug should be stored in a place inaccessible to children at a temperature not higher than 30 ° C.
Best before date Macrogol
The shelf life is five years.
Pharmacological effect Fortrans
Laxative. Macrogol 4000 is a linear polymer that holds water molecules by means of hydrogen bonds. This increases the osmotic pressure and the volume of intestinal contents.
The electrolytes included in the preparation prevent the body from disrupting the electrolyte water balance.
Testimony Fortrans
- Preparation for endoscopic or X-ray examination of the colon;
- Preparation for operative interventions that require no contents in the intestine.
Method of use, course and dosage Macrogol
The drug is administered to adults and adolescents over the age of 15. Before use, the contents of 1 bag are completely dissolved in 1 liter of water.
The dose of the preparation is set at the rate of 1 liter of the prepared solution on 15-20 kg of body weight (on average 3-4 liters of solution).
The necessary dose can be taken once - 4 liters in the evening, on the eve of the study or operation. This volume can be divided into two receptions - two liters the night before and 2 liters in the morning. The treatment should be completed 3-4 hours before the procedure.
- Nosology Fortrans Macrogol (ICD codes)
- Z51.4
- Preparatory procedures for follow-up treatment or examination not classified elsewhere
